Ralf Kuhlen

Professor Ralf Kuhlen is an accomplished medical professional with a wealth of experience in clinical practice, research, and healthcare leadership. After his training as anesthetist and intensivist, he held clinical positions as Head of Intensive Care departments for more than 10 years, first at the University Hospital Aachen, Germany, and since 2007 at the Helios Hospital in Berlin Buch. Since 2010 he served as Chief Medical Officer (CMO) for the Helios Group, overseeing Helios Germany as the biggest hospital group in Germany and Quironsalud, as the biggest group in Spain. Ralf provided groupwide leadership for the development of medical strategies focusing on highest medical quality by ensuring evidence-based, safe, effective and efficient care for all patients. Driven by the conviction that measuring clinical outcomes is essential for improvement, he was highly engaged in establishing and further developing outcome oriented quality management systems at Helios and Quironsalud. He was also one of the founders of the Initiative of Quality Medicine (IQM) in Germany, where he is leading the scientific board since its beginning in 2008. One of his key priorities has been to drive the evolution of medical innovations in a way that truly benefits our patients. He is committed to ensuring that innovations are focused on clinical needs and create value to the patients first, but also to the healthcare systems for the sake of sustainable quality, safety, and accessibility. Since April 2024, Professor Kuhlen has taken on the role of Chief Medical Officer at Fresenius where he is responsible for the global development of medical initiatives. Fresenius offers a rather unique combination of a (Bio) Pharma, Nutrition, and MedTech Company, Fresenius Kabi, and the biggest hospital group in Germany, Fresenius Helios, which provides a meaningful perspective on the different challenges our healthcare systems face. With over 200 scientific publications in renowned journals, Professor Kuhlen is a recognized expert in his field. His work spans a range of topics, including the integration of digital health solutions to improve patient care and access. He is particularly passionate about leveraging technology to advance healthcare and is a strong advocate for addressing antimicrobial resistance (AMR) through evidence-based policies.